Non‐insulin antihyperglycaemic drugs and heart failure: an overview of current evidence from randomized controlled trials

Type 2 diabetes mellitus (T2DM) is highly prevalent in the general population and especially in patients with heart failure (HF). It is not only a risk factor for incident HF, but is also associated with worse outcomes in prevalent HF. Therefore, antihyperglycaemic management in patients at risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Savarese, Gianluigi, Schrage, Benedikt, Cosentino, Francesco, Lund, Lars H., Rosano, Giuseppe M.C., Seferovic, Petar, Butler, Javed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755024/
https://www.ncbi.nlm.nih.gov/pubmed/32909376
http://dx.doi.org/10.1002/ehf2.12937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7755024/
https://www.ncbi.nlm.nih.gov/pubmed/32909376
http://dx.doi.org/10.1002/ehf2.12937

Ejemplares similares